| Published Version Download ( PDF | 2MB) | License: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0 |
Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands †
Pockes, Steffen, Wifling, David
, Buschauer, Armin
and Elz, Sigurd
(2019)
Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands †.
ChemistryOpen 8 (3), pp. 285-297.
Date of publication of this fulltext: 16 Dec 2019 09:37
Article
DOI to cite this document: 10.5283/epub.41284
Abstract
New classes of alkylated hetarylpropylguanidines with different functionality and variation in spacer length were synthesized to determine their behavior at the four histamine receptor (H1R, H2R, H3R, H4R) subtypes. Alkylated guanidines with different terminal functional groups and varied basicity, like amine, guanidine and urea were developed, based on the lead structure SK&F 91486 (2). ...
New classes of alkylated hetarylpropylguanidines with different functionality and variation in spacer length were synthesized to determine their behavior at the four histamine receptor (H1R, H2R, H3R, H4R) subtypes. Alkylated guanidines with different terminal functional groups and varied basicity, like amine, guanidine and urea were developed, based on the lead structure SK&F 91486 (2). Furthermore, heteroatomic exchange at the guanidine structure of 2 led to simple analogues of the lead compound. Radioassays at all histamine receptor subtypes were accomplished, as well as organ bath studies at the guinea pig (gp) ileum (gpH(1)R) and right atrium (gpH(2)R). Ligands with terminal functionalization led to, partially, highly affine and potent structures (two digit nanomolar), which showed up a bad selectivity profile within the histamine receptor family. While the benzoylurea derivative 144 demonstrated a preference towards the human (h) H3R, S-methylisothiourea analogue 143 obtained high affinity at the hH(4)R (pK(i)=8.14) with moderate selectivity. The molecular basis of the latter finding was supported by computational studies.
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | ChemistryOpen | ||||
| Publisher: | Wiley | ||||
|---|---|---|---|---|---|
| Place of Publication: | WEINHEIM | ||||
| Volume: | 8 | ||||
| Number of Issue or Book Chapter: | 3 | ||||
| Page Range: | pp. 285-297 | ||||
| Date | 5 March 2019 | ||||
| Institutions | Chemistry and Pharmacy > Institute of Pharmacy Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical/Medicinal Chemistry I (Prof. Elz) | ||||
| Identification Number |
| ||||
| Keywords | G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; IN-VITRO PHARMACOLOGY; H-4 RECEPTOR; H3 RECEPTOR; HIGHLY POTENT; 1ST POTENT; H-2-RECEPTOR; CLONING; AGONIST; BINDING; histamine H1-4 receptor; ligand design; receptor subtype selectivity; organ pharmacology; computational chemistry | ||||
| Dewey Decimal Classification | 600 Technology > 615 Pharmacy | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| URN of the UB Regensburg | urn:nbn:de:bvb:355-epub-412846 | ||||
| Item ID | 41284 |
Download Statistics
Download Statistics